Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Oct
4
2022
US Executive Branch Update – October 3, 2022 Squire Patton Boggs (US) LLP
Oct
3
2022
Living the High Life: Separation of Work and Home? Mintz
Oct
3
2022
UPSTO Extends Pilot Programs Foley & Lardner LLP
Oct
3
2022
Attention New Jersey Employers: NJ Cannabis Regulatory Commission Issues Interim Guidance on Workplace Impairment Greenberg Traurig, LLP
Oct
3
2022
New FDA Guidance Allows Companies to Continue Marketing Infant Formula Under an Enforcement Discretion Letter Beyond November 14, 2022 Keller and Heckman LLP
Oct
3
2022
FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Sep
30
2022
OECD Accepting Comment on Draft Study Report on Applicability of the Key Event Based TG 442D for In Vitro Skin Sensitisation Testing of Nanomaterials Bergeson & Campbell, P.C.
Sep
30
2022
Medical Marijuana and the Construction Job Site Jackson Lewis P.C.
Sep
30
2022
USDA Focused on Accurate “Made in the USA” Beef Labeling Keller and Heckman LLP
Sep
30
2022
All Things Chemical® Podcast: The New Era of Smarter Food Safety — A Conversation with Karin Baron [PODCAST] Bergeson & Campbell, P.C.
Sep
29
2022
Wined and Fined: OFSI Imposes Financial Penalty on UK Company for Publicising Sanctioned Crimean Winery Greenberg Traurig, LLP
Sep
29
2022
QR Code and Text Messaging Alone Are Insufficient to Disclose Bioengineered Food Ingredients K&L Gates LLP
Sep
29
2022
FDA Proposes Updated Definition for “Healthy” Claim Keller and Heckman LLP
Sep
29
2022
California Federal Court Substantially Upholds Bioengineered Food Disclosure But Remands QR Code and Text Message Disclosure Options to USDA for Further Rulemaking ArentFox Schiff LLP
Sep
29
2022
MintzRx — Medicaid Best Price Value Based Purchasing Rules Took Effect July 1, 2022 Mintz
Sep
29
2022
MintzRx — Pressure to Combat High Drug Prices Lands PBMs in the Hot Seat Mintz
Sep
29
2022
MintzRx — Drug Pricing Update: The Inflation Reduction Act Mintz
Sep
28
2022
4th Quarter 2022 Quick Hits for Plan Sponsors and Administrators Jackson Lewis P.C.
Sep
28
2022
Tension Over Copay Assistance and Maximizer Programs Continues Mintz
Sep
28
2022
MintzRx — Summer 2022 Enforcement Round-Up: Key Trends in Pharmacy Enforcement Actions Mintz
Sep
28
2022
MintzRx — Digital Health Update: Federal Government Shows Growing Enforcement Interest in Online Prescribing of Controlled Substances Mintz
Sep
28
2022
California Enacts Legal Protections for Cannabis Insurance Providers Wilson Elser Moskowitz Edelman & Dicker LLP
Sep
28
2022
Mere Puffery vs False Advertising: Recent Trends ArentFox Schiff LLP
Sep
28
2022
Developers Take Note: FDA Issues Clinical Decision Support Software Final Guidance Foley & Lardner LLP
Sep
28
2022
New Report Outlines FDA’s Strategy to Ensure the Safety of Imported Produce Keller and Heckman LLP
Sep
27
2022
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians Robinson & Cole LLP
Sep
27
2022
FDA Is Accepting EUA Requests for Monkeypox Tests, But Time is of the Essence Mintz
Sep
27
2022
Health Foods in China: New Rules Approving Functional Claims Keller and Heckman LLP
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters